Cancer Research Malaysia is registered as a company limited by guarantee, making us an autonomous, non-profit research organization with tax exemption status awarded by the Malaysian Inland Revenue Board. Our affairs are governed by the Cancer Research Malaysia Board of Trustees.

The Board of Trustees sets the strategic direction, determines key policies, and oversees governance of CRM by supervising the delegation of authority to its various committees, and ensuring that we achieve our objectives. The Board meets quarterly, and comprises of 8 members who are nominated and appointed by the Board, and approved by the Minister of Domestic Trade and Industry.
MS LEELA BARROCK

MS LEELA BARROCK

Leela Barrock is the Principal of Leela Barrock & Associates Sdn. Bhd. (LBA), an independent communications consultancy specializing in strategic reputation management and advocacy.

Ms. Barrock has more than 20 years of experience in the media and communications industry. Before establishing LBA, Ms. Barrock was the Group Head of Communications in Sime Darby Berhad, overseeing the functions of Group Communications, Corporate Affairs and Investor Relations. She provided strategic direction for Sime Darby’s global stakeholder engagement and communications initiatives, the Group’s corporate brand positioning and the streamlining of relevant corporate policies and commitments. Ms. Barrock was also responsible for providing guidance and ensuring alignment of the Group’s engagements with the investment community.

Prior to joining Sime Darby Berhad, Ms. Barrock was a journalist for 14 years, commencing her career with financial daily, Business Times. In 2000, she joined Malaysia’s leading financial and investment weekly, The Edge, covering capital markets and the corporate sector. Her main areas of coverage were the plantation and commodities sector, the auto sector and, media and regulatory developments in the capital markets. Ms. Barrock was Associate Editor of The Edge when she left in 2008.

Ms. Barrock obtained her LLB (Hons) from the University of London in 1990 and was admitted to the Bar of England and Wales in 1992. She read in chambers at Skrine & Company but left the legal profession to pursue her career in journalism in 1994.
Datuk Professor Dr Looi Lai Meng

Datuk Professor Dr Looi Lai Meng

Datuk Professor Dr Looi Lai Meng is Malaysia’s inaugural National Distinguished Professor positioned in the Faculty of Medicine, University of Malaya (UM).  She holds a concurrent appointment as senior consultant histopathologist at the University of Malaya Medical Centre (UMMC).    

Professor Dr Looi studied medicine as a Malaysian Federal Scholar at the University of Singapore, where she was a medallist in Pathology and Social Medicine, and won King Edward VII Hall awards for literary works, art forms and poetry.  She trained in Surgical Pathology at UM, Royal Postgraduate Medical School (UK) and Brigham and Woman’s Hospital, Boston, (USA) and defended her research doctorate (on amyloidosis) at UM.  She has more than 200 peer-reviewed publications and is devoted to promoting a research and ethical culture among researchers.

Datuk Professor Dr Looi is an Examiner of both Royal Colleges of Pathologists, UK (RCPath) and Australasia (RCPA), Founding President of Malaysia’s College of Pathologists and Founding Fellow and Academician of the Academy of Sciences Malaysia. She was instrumental in establishing pathology laboratory accreditation in Malaysia, the Pathology Act and several pathology practice reference guidelines for Malaysia. She co-chaired the InterAcademy Medical Panel (now the InterAcademy Partnership for Health) for two elected terms and has also served as President of the World Association of Societies of Pathology and Laboratory Medicine (WASPaLM). She has been honoured with Malaysia’s National Science Award, the Merdeka Award 2016 (Health, Science and Technology category), the ASEAN Outstanding Scientist Award, Distinguished RCPA Fellow and the WASPaLM Gold-headed Cane. She was conferred Honorary Professor by the Chinese Academy of Medical Sciences-Peking Union Medical College in 2017.

Datuk Professor Dr Looi Lai Meng joined Cancer Research Malaysia as a Board Member of Trustee in August 2018.